Shots target group B streptococcus, a little-known microbe that can cause stillbirths and life-threatening disease in infants



Summary

Group B streptococcus (GBS) is a common bacteria that poses a significant threat to newborns. While often asymptomatic in adults, it can lead to stillbirths, sepsis, pneumonia, and meningitis in infants. Developing vaccines against GBS is crucial to prevent these devastating outcomes. These shots aim to protect pregnant women, allowing them to pass protective antibodies to their babies, thus reducing the incidence of life-threatening GBS infections and improving infant health worldwide. Current research focuses on creating effective and safe vaccines for widespread use.

Read more…

Credits: Source

This post is part of “Science/Immunology News”, Follow for more…!!!